Patrick Blaney

559 total citations
16 papers, 109 citations indexed

About

Patrick Blaney is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Patrick Blaney has authored 16 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Patrick Blaney's work include Multiple Myeloma Research and Treatments (15 papers), Cancer Genomics and Diagnostics (7 papers) and Protein Degradation and Inhibitors (6 papers). Patrick Blaney is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Cancer Genomics and Diagnostics (7 papers) and Protein Degradation and Inhibitors (6 papers). Patrick Blaney collaborates with scholars based in United States, United Kingdom and Norway. Patrick Blaney's co-authors include Gareth J. Morgan, Eileen M. Boyle, Francesco Maura, Ola Landgren, Michael Bauer, Even H Rustad, Louis Williams, Brian A. Walker, Kylee Maclachlan and Faith E. Davies and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Patrick Blaney

15 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Blaney United States 6 78 58 24 23 15 16 109
Courteney K. Lai Germany 6 68 0.9× 50 0.9× 14 0.6× 13 0.6× 9 0.6× 8 104
Sofia Bakogianni United States 2 186 2.4× 39 0.7× 25 1.0× 16 0.7× 23 1.5× 2 208
Claudia Lanauze United States 2 110 1.4× 28 0.5× 13 0.5× 20 0.9× 7 0.5× 2 142
Georgina L. Ryland Australia 3 60 0.8× 20 0.3× 35 1.5× 16 0.7× 22 1.5× 4 98
Anna Palau Spain 5 179 2.3× 83 1.4× 23 1.0× 14 0.6× 14 0.9× 8 214
Júlia Aguadé-Gorgorió Switzerland 5 154 2.0× 61 1.1× 20 0.8× 40 1.7× 7 0.5× 7 198
Hayato Tamai Japan 6 78 1.0× 60 1.0× 14 0.6× 28 1.2× 15 1.0× 19 145
Guillaume Hypolite France 8 77 1.0× 59 1.0× 13 0.5× 21 0.9× 10 0.7× 10 151
Natasha Silke Australia 6 87 1.1× 19 0.3× 21 0.9× 32 1.4× 7 0.5× 9 127
Venkata D. Yellapantula United States 5 64 0.8× 63 1.1× 29 1.2× 34 1.5× 11 0.7× 14 91

Countries citing papers authored by Patrick Blaney

Since Specialization
Citations

This map shows the geographic impact of Patrick Blaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Blaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Blaney more than expected).

Fields of papers citing papers by Patrick Blaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Blaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Blaney. The network helps show where Patrick Blaney may publish in the future.

Co-authorship network of co-authors of Patrick Blaney

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Blaney. A scholar is included among the top collaborators of Patrick Blaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Blaney. Patrick Blaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ghamlouch, Hussein, Patrick Blaney, Eileen M. Boyle, et al.. (2025). A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche. Experimental Hematology and Oncology. 14(1). 22–22. 1 indexed citations
2.
Kazandjian, Dickran, Benjamin Diamond, Romanos Sklavenitis‐Pistofidis, et al.. (2024). Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. Clinical Cancer Research. 30(19). 4482–4490. 5 indexed citations
3.
Ghamlouch, Hussein, et al.. (2024). Bone Marrow Fibroblasts at the Single-Cell Resolution Level in Multiple Myeloma. Blood. 144(Supplement 1). 4636–4636. 1 indexed citations
4.
Johnson, Travis S., Parvathi Sudha, Patrick Blaney, et al.. (2024). 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature Communications. 15(1). 4144–4144. 3 indexed citations
5.
Chojnacka, Monika, Benjamin Diamond, Bachisio Ziccheddu, et al.. (2023). Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma. Clinical Cancer Research. 30(3). 575–585. 1 indexed citations
6.
7.
Diamond, Benjamin, Dickran Kazandjian, Bachisio Ziccheddu, et al.. (2023). Genomic Profiling to Interpret the Outcomes of Early Intervention for High-Risk Smoldering Myeloma. Blood. 142(Supplement 1). 757–757. 1 indexed citations
8.
Braunstein, Marc, Patrick Blaney, & Gareth J. Morgan. (2023). Whole-Genome Sequencing Identifies Structural Variation As a Key Driver of Disease Relapse and Aggressive Clinical Behavior in Multiple Myeloma. Blood. 142(Supplement 1). 2773–2773. 1 indexed citations
9.
Ashby, Cody, Eileen M. Boyle, Michael Bauer, et al.. (2022). Structural variants shape the genomic landscape and clinical outcome of multiple myeloma. Blood Cancer Journal. 12(5). 85–85. 10 indexed citations
10.
Boyle, Eileen M., Patrick Blaney, Yubao Wang, et al.. (2021). Unifying the Definition of High-Risk in Multiple Myeloma. Blood. 138(Supplement 1). 2714–2714.
11.
Maura, Francesco, Eileen M. Boyle, Even H Rustad, et al.. (2021). Chromothripsis as a pathogenic driver of multiple myeloma. Seminars in Cell and Developmental Biology. 123. 115–123. 25 indexed citations
12.
Maclachlan, Kylee, Even H Rustad, Andriy Derkach, et al.. (2021). Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma. Nature Communications. 12(1). 5172–5172. 26 indexed citations
13.
Ghamlouch, Hussein, Eileen M. Boyle, Patrick Blaney, et al.. (2021). Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 380–380. 8 indexed citations
14.
15.
Boyle, Eileen M., Louis Williams, Patrick Blaney, et al.. (2020). Influence of Aging Processes on the Biology and Outcome of Multiple Myeloma. Blood. 136(Supplement 1). 8–9. 1 indexed citations
16.
Clark, Christopher, Patrick Blaney, Sambhawa Priya, et al.. (2018). Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Scientific Reports. 8(1). 15327–15327. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Courteney K. Lai Breakdown of academic impact, for papers by Sofia Bakogianni Breakdown of academic impact, for papers by Claudia Lanauze Breakdown of academic impact, for papers by Georgina L. Ryland Breakdown of academic impact, for papers by Anna Palau Breakdown of academic impact, for papers by Júlia Aguadé-Gorgorió Breakdown of academic impact, for papers by Hayato Tamai Breakdown of academic impact, for papers by Guillaume Hypolite Breakdown of academic impact, for papers by Natasha Silke Breakdown of academic impact, for papers by Venkata D. Yellapantula
Rankless by CCL
2026